Skip to main content
. 2020 May 18;8(7):3212–3224. doi: 10.1002/fsn3.1581

Figure 3.

Figure 3

The assessment on NAFLD model in vitro. (a) Cytotoxicity assay. Cell viability in all ASP treatment groups (from 200 to 1,200 μg/ml) was above 80%. (b) The TC level in cells supernatant. TC in model control was significantly higher than normal control group (aaa p < .001). All ASP groups were significantly different from model control group (***p < .001) and ASP reduced TC level in a dose‐dependent manner. (c) The TG level of cells supernatant. TG in model control was significantly higher than normal control group (aaa p < .001). All ASP groups were significantly different from model control group (***p < .001) and ASP reduced TG level in a dose‐dependent manner. (d) Semiquantitative analysis of Oil Red O staining. Oil Red O (ORO)‐positive area in model control group was significantly higher than normal control group (aaa p < .001). The ASP‐high group significantly reduced ORO‐positive area (*p < .05). (e) Oil Red O staining assessment. ASP reduced red lipid in a dose‐dependent manner (scale bar 100 μm). (f) Nile red staining assessment. ASP alleviated red fluorescent intensity in a dose‐dependent manner (scale bar 100 μm)